CALT - Calliditas Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $40.93. This is a potential upside of $0.93 (2.33%) from yesterday's end of day stock price of $40.

Calliditas Therapeutics's activity chart (see below) currently has 41 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.58% with an average time for these price targets to be met of 143.75 days.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 31-May-2024. First documented stock forecast 30-Jun-2020.

Best performing analysts who are covering CALT - Calliditas Therapeutics:

Annabel Samimy Yigal Nochomovitz Vamil Divan Maury Raycroft

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$39

$-1 (-2.50%)

$74

1 years 6 months 11 days ago
(31-May-2024)

2/6 (33.33%)

$-0.99 (-2.48%)

82

Hold

$40

$48

1 years 6 months 14 days ago
(28-May-2024)

3/5 (60%)

$2.05 (5.40%)

469

Hold

$39

$-1 (-2.50%)

$58

1 years 6 months 14 days ago
(28-May-2024)

1/4 (25%)

$1.05 (2.77%)

3

Hold

$18

$-22 (-55.00%)

$18

2 years 3 months 24 days ago
(18-Aug-2023)

2/2 (100%)

$1.6 (9.76%)

21

Show more analysts

Please expand the browser size to see the chart

What is CALT (Calliditas Therapeutics) average time for price targets to be met?

On average it took 143.75 days on average for the stock forecasts to be realized with a an average price target met ratio 54.58

Which analyst has the current highest performing score on CALT (Calliditas Therapeutics) with a proven track record?

ANNABEL SAMIMY

Which analyst has the current lower performing score on CALT (Calliditas Therapeutics) with a proven track record?

MAURY RAYCROFT

Which analyst has the most public recommendations on CALT (Calliditas Therapeutics)?

Annabel Samimy works at STIFEL and has 3 price targets and 2 ratings on CALT

Which analyst is the currently most bullish on CALT (Calliditas Therapeutics)?

Annabel Samimy with highest potential upside - $0

Which analyst is the currently most reserved on CALT (Calliditas Therapeutics)?

Vamil Divan with lowest potential downside - -$22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?